CAD 7.15
(1.85%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 588.62 Million USD | -13.69% |
2022 | 682 Million USD | 20.47% |
2021 | 566.13 Million USD | 46.51% |
2020 | 386.41 Million USD | 6.66% |
2019 | 362.28 Million USD | 243.19% |
2018 | 105.56 Million CAD | 473.03% |
2017 | 18.42 Million CAD | 796.16% |
2016 | -2.64 Million CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 181.64 Million USD | 4.51% |
2024 Q1 | 173.8 Million USD | 12.97% |
2023 Q3 | 142.94 Million USD | 0.95% |
2023 Q4 | 153.85 Million USD | 7.63% |
2023 Q1 | 149.9 Million USD | 0.13% |
2023 Q2 | 141.6 Million USD | -5.54% |
2023 FY | 588.62 Million USD | -13.69% |
2022 Q2 | 182.15 Million USD | 2.25% |
2022 Q4 | 149.7 Million USD | -10.91% |
2022 FY | 682 Million USD | 20.47% |
2022 Q1 | 178.15 Million USD | 34.52% |
2022 Q3 | 168.03 Million USD | -7.75% |
2021 Q4 | 132.43 Million USD | -13.97% |
2021 Q3 | 153.94 Million USD | 6.55% |
2021 Q2 | 144.48 Million USD | 6.82% |
2021 Q1 | 135.26 Million USD | -17.54% |
2021 FY | 566.13 Million USD | 46.51% |
2020 Q1 | 62.7 Million USD | -42.07% |
2020 Q4 | 164.02 Million USD | 92.1% |
2020 Q3 | 85.38 Million USD | 14.94% |
2020 FY | 386.41 Million USD | 6.66% |
2020 Q2 | 74.29 Million USD | 18.47% |
2019 Q4 | 108.24 Million USD | -1.71% |
2019 Q1 | 40.11 Million USD | 18.86% |
2019 FY | 362.28 Million USD | 243.19% |
2019 Q2 | 103.78 Million USD | 158.75% |
2019 Q3 | 110.13 Million USD | 6.11% |
2018 Q1 | 14.71 Million USD | 101.95% |
2018 Q3 | 35.75 Million USD | 76.28% |
2018 FY | 105.56 Million CAD | 473.03% |
2018 Q4 | 33.74 Million USD | -5.61% |
2018 Q2 | 20.28 Million USD | 37.86% |
2017 FY | 18.42 Million CAD | 796.16% |
2017 Q2 | -3.03 Million USD | -406.87% |
2017 Q4 | 7.28 Million USD | 132.23% |
2017 Q3 | 3.13 Million USD | 203.26% |
2017 Q1 | -599.37 Thousand USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | -2.64 Million CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aion Therapeutic Inc. | -285.33 Thousand CAD | 206393.655% |
Ayurcann Holdings Corp. | 8.46 Million CAD | -6853.405% |
Blueberries Medical Corp. | 84.22 Thousand CAD | -698775.631% |
The BC Bud Corporation | 59.5 Thousand CAD | -989140.879% |
BioNxt Solutions Inc. | 372.24 Thousand CAD | -158028.34% |
CordovaCann Corp. | 3.26 Million CAD | -17903.818% |
Christina Lake Cannabis Corp. | 3.46 Million CAD | -16882.146% |
Captor Capital Corp. | 16.93 Million CAD | -3375.277% |
City View Green Holdings Inc. | -290.73 Thousand CAD | 202559.947% |
1CM Inc. | 7.6 Million CAD | -7636.254% |
Global Hemp Group Inc. | - CAD | -Infinity% |
Greenway Greenhouse Cannabis Corporation | -335.37 Thousand CAD | 175612.334% |
IM Cannabis Corp. | 9.84 Million CAD | -5878.347% |
Lobe Sciences Ltd. | 772.82 Thousand CAD | -76065.657% |
Maple Leaf Green World Inc. | -17.85 Thousand CAD | 3296997.054% |
Mountain Valley MD Holdings Inc. | -346 Thousand CAD | 170223.699% |
Nextleaf Solutions Ltd. | 1.24 Million CAD | -47086.047% |
Ovation Science Inc. | -251.43 Thousand CAD | 234211.148% |
Pharmadrug Inc. | -26.21 Thousand CAD | 2245400.58% |
Captiva Verde Wellness Corp. | 163.43 Thousand CAD | -360066.92% |
RAMM Pharma Corp. | -902.83 Thousand CAD | 65297.666% |
RIV Capital Inc. | -958.27 Thousand CAD | 61525.599% |
Revive Therapeutics Ltd. | -328.00 CAD | 179459856.098% |
Red White & Bloom Brands Inc. | 29.48 Million CAD | -1896.35% |
SLANG Worldwide Inc. | 18.61 Million CAD | -3061.366% |
1933 Industries Inc. | -602.75 Thousand CAD | 97755.776% |
Red Light Holland Corp. | 2.02 Million CAD | -29033.25% |
Top Strike Resources Corp. | 2.84 Million CAD | -20575.741% |
Xebra Brands Ltd. | -367.96 Thousand CAD | 160068.91% |
Adastra Holdings Ltd. | 7.03 Million CAD | -8272.651% |